Free Trial

Select Medical (SEM) Competitors

$33.26
+0.33 (+1.00%)
(As of 05/28/2024 ET)

SEM vs. EHC, IMVT, ALPN, NUVL, RDNT, INSP, TMDX, PACS, CRSP, and ALKS

Should you be buying Select Medical stock or one of its competitors? The main competitors of Select Medical include Encompass Health (EHC), Immunovant (IMVT), Alpine Immune Sciences (ALPN), Nuvalent (NUVL), RadNet (RDNT), Inspire Medical Systems (INSP), TransMedics Group (TMDX), PACS Group (PACS), CRISPR Therapeutics (CRSP), and Alkermes (ALKS). These companies are all part of the "medical" sector.

Select Medical vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, community ranking, earnings, profitability, risk, media sentiment and valuation.

Encompass Health has a net margin of 7.60% compared to Select Medical's net margin of 3.97%. Select Medical's return on equity of 18.11% beat Encompass Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical3.97% 18.11% 3.64%
Encompass Health 7.60%18.01%6.55%

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 23.8% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Select Medical has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

89.5% of Select Medical shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 17.5% of Select Medical shares are held by insiders. Comparatively, 2.1% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.66B0.65$243.49M$2.1015.88
Encompass Health$4.80B1.77$352M$3.7022.82

In the previous week, Encompass Health had 10 more articles in the media than Select Medical. MarketBeat recorded 15 mentions for Encompass Health and 5 mentions for Select Medical. Encompass Health's average media sentiment score of 0.80 beat Select Medical's score of 0.45 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Encompass Health
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Encompass Health received 160 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.87% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
328
57.85%
Underperform Votes
239
42.15%
Encompass HealthOutperform Votes
488
71.87%
Underperform Votes
191
28.13%

Select Medical currently has a consensus price target of $34.25, indicating a potential upside of 3.22%. Encompass Health has a consensus price target of $92.00, indicating a potential upside of 9.16%. Given Encompass Health's stronger consensus rating and higher probable upside, analysts plainly believe Encompass Health is more favorable than Select Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Summary

Encompass Health beats Select Medical on 16 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEM vs. The Competition

MetricSelect MedicalHospitals IndustryMedical SectorNYSE Exchange
Market Cap$4.34B$4.47B$4.94B$17.72B
Dividend Yield1.52%1.12%2.80%3.53%
P/E Ratio15.8812.84129.4022.62
Price / Sales0.650.912,531.8310.26
Price / Cash9.088.9432.6015.70
Price / Book2.762.414.955.10
Net Income$243.49M$178.36M$103.73M$974.28M
7 Day Performance-2.63%-1.99%-1.00%-1.14%
1 Month Performance21.67%1.27%3.41%4.77%
1 Year Performance23.02%5.90%5.15%23.90%

Select Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EHC
Encompass Health
4.9168 of 5 stars
$85.80
-0.4%
$90.29
+5.2%
+41.0%$8.64B$4.80B23.1938,000Short Interest ↓
IMVT
Immunovant
1.0831 of 5 stars
$30.30
-1.8%
$48.00
+58.4%
+37.5%$4.40BN/A-16.47164News Coverage
ALPN
Alpine Immune Sciences
1.6995 of 5 stars
$64.97
flat
$52.33
-19.5%
+556.3%$4.46B$58.88M-101.52142Positive News
NUVL
Nuvalent
2.3966 of 5 stars
$69.73
-1.7%
$90.78
+30.2%
+68.9%$4.47BN/A-28.9392Positive News
RDNT
RadNet
3.1606 of 5 stars
$58.23
-0.4%
$57.25
-1.7%
+102.4%$4.30B$1.62B194.1010,288Positive News
INSP
Inspire Medical Systems
4.9674 of 5 stars
$152.42
-1.8%
$256.53
+68.3%
-46.1%$4.53B$624.80M-277.131,011Short Interest ↓
Positive News
TMDX
TransMedics Group
2.4347 of 5 stars
$138.42
-0.1%
$119.00
-14.0%
+98.5%$4.56B$241.62M-407.12584Positive News
PACS
PACS Group
1.427 of 5 stars
$27.68
-3.0%
$31.00
+12.0%
N/A$4.16BN/A0.0032,433
CRSP
CRISPR Therapeutics
2.242 of 5 stars
$54.76
-1.3%
$73.93
+35.0%
-14.6%$4.65B$371.21M-20.13473Short Interest ↑
ALKS
Alkermes
4.8151 of 5 stars
$24.34
-0.2%
$35.38
+45.3%
-18.1%$4.12B$1.66B9.622,100Analyst Revision

Related Companies and Tools

This page (NYSE:SEM) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners